These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 223814)

  • 41. Presence of immunoreactive luteinizing hormone-releasing factor in hydatidiform mole as compared with normal human trophoblastic tissue.
    Osathanondh R; Elkind-Hirsch KE
    Placenta Suppl; 1981; 3():257-61. PubMed ID: 6763999
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The role of regional centers for gestational trophoblastic disease.
    Goldstein DP; Berkowitz RS
    Adv Exp Med Biol; 1984; 176():383-400. PubMed ID: 6093470
    [No Abstract]   [Full Text] [Related]  

  • 43. Gestational trophoblastic tumours. Two. Choriocarcinoma.
    Willmot L
    Nurs Times; 1984 Feb 15-21; 80(7):42-4. PubMed ID: 6560506
    [No Abstract]   [Full Text] [Related]  

  • 44. Worldwide controversies in gestational trophoblastic neoplasms.
    Goldstein DP
    Int J Gynaecol Obstet; 1977; 15(3):207-15. PubMed ID: 205453
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hydatidiform mole. A follow-up regimen for identification of invasive mole and choriocarcinoma and for selection of patients for treatment.
    Brewer JI; Torok EE; Webster A; Dolkart RE
    Am J Obstet Gynecol; 1968 Jun; 101(4):557-63. PubMed ID: 5690298
    [No Abstract]   [Full Text] [Related]  

  • 46. Invasive mole and gestational choriocarcinoma in Denmark, 1940-1969. Biological and clinical aspects.
    Mogensen B
    Acta Obstet Gynecol Scand; 1973; 52(3):211-20. PubMed ID: 4355252
    [No Abstract]   [Full Text] [Related]  

  • 47. Inhibin: a new circulating marker of hydatidiform mole?
    Yohkaichiya T; Fukaya T; Hoshiai H; Yajima A; de Kretser DM
    BMJ; 1989 Jun; 298(6689):1684-6. PubMed ID: 2503176
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The beta-subunit of chorionic gonadotrophin as a tumour marker in gestational trophoblastic disease.
    Khoo SK; Daunter B
    Aust N Z J Obstet Gynaecol; 1980 Feb; 20(1):35-42. PubMed ID: 6248013
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Polyamines and nucleic acids in gestational trophoblastic tumors.
    Romano M; Cecco L; Cerra M; Pasquinelli R; Pagnano AM; Paladini A
    Tumori; 1985 Feb; 71(1):35-8. PubMed ID: 2984816
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Possible new markers in trophoblastic diseases.
    Inaba N; Ishige H; Ijichi M; Satoh N; Katoh T; Sekiya S; Shirotake S; Ohkawa R; Takamizawa H; Nitoh A; Renk T; Bohn H
    Am J Obstet Gynecol; 1982 Aug; 143(8):973-4. PubMed ID: 6980595
    [No Abstract]   [Full Text] [Related]  

  • 51. Radioimmunoassay of the serum free beta-subunit of human chorionic gonadotropin in trophoblastic disease.
    Fan C; Goto S; Furuhashi Y; Tomoda Y
    J Clin Endocrinol Metab; 1987 Feb; 64(2):313-8. PubMed ID: 2432080
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Management of gestational trophoblastic diseases in Japan--a review.
    Sasaki S
    Placenta; 2003 Apr; 24 Suppl A():S28-32. PubMed ID: 12842411
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Amethopterin in the treatment of trophoblastic tumors.
    MANAHAN CP; BENITEZ I; ESTRELLA F
    Am J Obstet Gynecol; 1961 Sep; 82():641-5. PubMed ID: 13766006
    [No Abstract]   [Full Text] [Related]  

  • 54. Hormonal contraception and trophoblastic sequelae after hydatidiform mole (a Gynecologic Oncology Group Study).
    Curry SL; Schlaerth JB; Kohorn EI; Boyce JB; Gore H; Twiggs LB; Blessing JA
    Am J Obstet Gynecol; 1989 Apr; 160(4):805-9; discussion 809-11. PubMed ID: 2540654
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Treatment and care of patients with malignant and semi-malignant forms of trophoblastic disease in the National Center in Prague].
    Skrivan J; Hausner P; Jakoubková J; Polák J; Růzková M; Vlachová J; Zavadil M
    Cesk Gynekol; 1984 Jul; 49(6):425-7. PubMed ID: 6488336
    [No Abstract]   [Full Text] [Related]  

  • 56. Introduction: a success history for surgery and chemotherapy--gestational trophoblastic neoplasia.
    Martimbeau PW
    Semin Oncol; 1982 Jun; 9(2):155-6. PubMed ID: 6289458
    [No Abstract]   [Full Text] [Related]  

  • 57. Plasma testosterone levels in trophoblastic disease and the effects of oophorectomy and chemotherapy.
    Samaan NA; Smith JP; Rutledge FN; Barcellona JM
    J Clin Endocrinol Metab; 1972 Mar; 34(3):558-61. PubMed ID: 5011259
    [No Abstract]   [Full Text] [Related]  

  • 58. Treatment of malignant trophoblastic tumors. An analysis of 209 cases.
    Wang SL; Zhang CS; Peng HQ; Wu KH
    Chin Med J (Engl); 1991 Feb; 104(2):156-60. PubMed ID: 1651828
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Five years' experience with the chemotherapy of metastatic choriocarcinoma and related trophoblastic tumors in women.
    HERTZ R
    Cancer Chemother Rep; 1962 Feb; 16():341. PubMed ID: 13906930
    [No Abstract]   [Full Text] [Related]  

  • 60. Serum SP1, hPL and beta-hCG levels in trophoblastic diseases.
    Zhang WY; Yen GL
    Chin Med J (Engl); 1991 Dec; 104(12):995-8. PubMed ID: 1723674
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.